- Home
- INMB vs NCSM Comparison
INMB vs NCSM Comparison
Compare INMB & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- NCSM
- Stock Information
- Founded
- INMB 2015
- NCSM 2006
- Country
- INMB United States
- NCSM United States
- Employees
- INMB N/A
- NCSM N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- NCSM Oilfield Services/Equipment
- Sector
- INMB Health Care
- NCSM Energy
- Exchange
- INMB Nasdaq
- NCSM Nasdaq
- Market Cap
- INMB 68.9M
- NCSM 76.3M
- IPO Year
- INMB 2019
- NCSM 2017
- Fundamental
- Price
- INMB $2.91
- NCSM $30.50
- Analyst Decision
- INMB Buy
- NCSM
- Analyst Count
- INMB 4
- NCSM 0
- Target Price
- INMB $9.53
- NCSM N/A
- AVG Volume (30 Days)
- INMB 4.5M
- NCSM 6.4K
- Earning Date
- INMB 08-04-2025
- NCSM 08-04-2025
- Dividend Yield
- INMB N/A
- NCSM N/A
- EPS Growth
- INMB N/A
- NCSM N/A
- EPS
- INMB N/A
- NCSM 3.27
- Revenue
- INMB $50,000.00
- NCSM $168,704,000.00
- Revenue This Year
- INMB $203.60
- NCSM $7.17
- Revenue Next Year
- INMB $13,122.47
- NCSM $5.44
- P/E Ratio
- INMB N/A
- NCSM $9.25
- Revenue Growth
- INMB N/A
- NCSM 18.16
- 52 Week Low
- INMB $1.89
- NCSM $16.66
- 52 Week High
- INMB $11.64
- NCSM $38.95
- Technical
- Relative Strength Index (RSI)
- INMB 41.06
- NCSM 50.62
- Support Level
- INMB $2.62
- NCSM $29.65
- Resistance Level
- INMB $3.07
- NCSM $30.73
- Average True Range (ATR)
- INMB 0.25
- NCSM 0.66
- MACD
- INMB 0.24
- NCSM 0.04
- Stochastic Oscillator
- INMB 72.26
- NCSM 45.62
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.